NCT06483555: Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 104 planned
- Started
- 6 Feb 2025
- Primary completion
- Aug 2027
- Arms
- PurIST Basal
- Results
- None posted
- 3 Jul 2024: Trial registered
- 6 Feb 2025: Trial started